Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-02-24
1987-12-29
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514506, 546337, 546336, 544302, 544311, 544316, 544319, 544335, 564189, 564190, 564204, 564219, A61K 3144, A61K 3116, A61K 31165, C07D21336, C07C10319
Patent
active
047161752
ABSTRACT:
Certain substituted amides of saturated fatty acids are potent inhibitors of the enzyme acyl-CoA:cholesterol acyltransferase and are thus useful agents for inhibiting the intestinal absorption of cholesterol.
REFERENCES:
patent: 4410697 (1983-10-01), Torok et al.
Chem. Abstracts; Boyles et al., vol. 94, No. 121134w (1981).
Chem. Abstracts; Volkenshtein et al., vol. 104, 199590m (1986).
Hoefle Milton L.
Holmes Ann
Roth Bruce D.
Janssen Jerry F.
Richter J.
Schwartz Richard A.
Warner-Lambert & Company
LandOfFree
Saturated fatty acid amides as inhibitors of acyl-CoA:cholestero does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Saturated fatty acid amides as inhibitors of acyl-CoA:cholestero, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saturated fatty acid amides as inhibitors of acyl-CoA:cholestero will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-463427